Galapagos NV: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...
Wright Investors Service Comprehensive Report for Galapagos NV
Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...
Galapagos NV: Downgraded to Average
Is Galapagos NV a Good Long-Term Investment?
Galapagos NV (GLPGA) - Financial Analysis Review
Galapagos NV (GLPGA) - Financial Analysis Review Summary Galapagos NV (Galapagos) is a biotechnology company. The compa...
Galapagos NV: Upgraded to Above Average
Galapagos NV: Five Candidates in the Pipeline
The following is an excerpt from the Streetwise Reports interview with George Zavoico, managing director and senior equity an...
Galapagos NV (GLPG.AS): An Alpha Deal Group Life Sciences 100 Candidate - Buy-Side Intelligence Brief
Galapagos NV (GLPGA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Galapagos NV (GLPGA) - Pharmaceuticals & Healthcare - Deals and
Alliances Profile Summary Galapagos NV (Galapagos) is a